Featured Research

from universities, journals, and other organizations

Are patients making cost-effective treatment decisions?

Date:
September 23, 2013
Source:
University of Michigan Health System
Summary:
A new commentary says that involving patients in decisions about their medical treatment will not likely lead to cost savings or less overtreatment.

The idea of patients and their families being involved in decisions about their medical treatment ensures that patients’ values and preferences are taken into account.

But does it also result in less overtreatment and reduced costs? A new commentary by University of Michigan Comprehensive Cancer Center researchers says that’s an overstatement.

“The assumption that the doctor is pushing harder than the patient for the most aggressive treatment is misguided,” says Steven J. Katz, M.D., M.P.H., co-author on a commentary published today in the Journal of the American Medical Association.

Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends. But Katz and co-author Sarah Hawley, Ph.D., say that’s not necessarily the case.

In fact, some studies have suggested that more patient involvement in decisions may result in more extensive treatment.

The authors say that treatment decisions should be a partnership between doctor and patient.

“Patients are looking for the doctor to help them make the right decisions. We have a concern about overtreatment or doing more harm than good, which is something the patient and doctor need to work through. But we’re talking about a partnership here, not a conflict,” says Katz, professor of internal medicine and of health management and policy at the University of Michigan.

“Patients want better communication with their doctor. What they get out of that is they feel more satisfied with the clinical encounter. They have more certainty and confidence in the plan going forward,” says


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Steven J. Katz, MD; Sarah Hawley, PhD. The Value of Sharing Treatment Decision Making With Patients. Jama, September 2013 DOI: 10.1001/jama.2013.278944

Cite This Page:

University of Michigan Health System. "Are patients making cost-effective treatment decisions?." ScienceDaily. ScienceDaily, 23 September 2013. <www.sciencedaily.com/releases/2013/09/130923123823.htm>.
University of Michigan Health System. (2013, September 23). Are patients making cost-effective treatment decisions?. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/09/130923123823.htm
University of Michigan Health System. "Are patients making cost-effective treatment decisions?." ScienceDaily. www.sciencedaily.com/releases/2013/09/130923123823.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins